BH25 Alopecia in a Patient Undergoing Multiple Treatments for Multiple Sclerosis: A Rare Presentation and Case Review
June 2025
in “
British Journal of Dermatology
”
TLDR MS treatments can cause significant hair loss, affecting mental health.
A 33-year-old woman with multiple sclerosis (MS) experienced significant hair loss after undergoing various MS treatments, including glatiramer acetate, dimethyl fumarate, natalizumab, and cladribine. Despite changing treatments due to alopecia, her hair loss persisted and correlated with the effectiveness of the MS therapies. Scalp biopsies confirmed nonscarring alopecia with a telogen shift, and blood tests showed normal levels of relevant markers. The case highlights the link between MS medications and hair loss as a significant adverse effect, emphasizing the need to inform patients about this potential side-effect, which can severely impact mental health.